Cellulite News and Research

RSS

Cellulite describes a condition that is claimed to occur in most women, where the skin of the lower limbs, abdomen, and pelvic region becomes dimpled.

Cynosure launches two new products to expand portfolio of aesthetic treatments

Hologic’s Cynosure division announced today the launch of two new products that expand the Company’s growing portfolio of innovative aesthetic treatments — the TempSure Firm handpiece and a petite mask for SculpSure submental treatments.

From Hologic, Inc. 29 Jul 2019

Hologic’s Cynosure division introduces TempSure Surgical RF technology in North America

Hologic announced today the North American launch of the FDA-cleared TempSure Surgical RF technology, a new offering of the TempSure radiofrequency platform.

From Hologic, Inc. 18 Dec 2018

Fitness instructors' motivational comments influence women's body satisfaction

Exercise has been called a double-edged sword for women when it comes to body image as some types of exercise seem to improve body esteem, whereas others have the potential to lower it.

14 Dec 2018

Covestro to showcase innovative materials at MD&M West 2018

Medical devices and health care equipment are changing dramatically, and these new applications need innovative materials to bring them to life. For almost 50 years, OEMs have depended on advanced materials and expertise from Covestro LLC to bring life-saving and life-enhancing products to the health care market.

From Covestro LLC 7 Feb 2018

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX in the U.S. and Xiapex in Europe, today announced its financial results for the fourth quarter and full year ended December 31, 2015 and provided a corporate update.

14 Mar 2016

Syneron Medical reports revenue of $62.1 million for third quarter 2015

Syneron Medical Ltd., a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2015.

11 Nov 2015

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Cynosure, Inc. today announced that it has received a medical device license issued by Health Canada to market MonaLisa Touch® for the treatment of symptoms related to Genitourinary Syndrome of Menopause (GSM), including vaginal dryness, vaginal burning, vaginal itching, pain, dysuria and dyspareunia.

28 Oct 2015

RENU 28 skin gel effectively improves skin elasticity, appearance of cellulite

ASEA, an emerging global leader in cellular health, today announced findings from a skin study conducted by leading dermatological research institute Dermatest. The study showed that RENU 28 skin gel effectively improves the appearance of cellulite as a result of the reduction of the size of adipose lobules. Additionally, the study showed significant improvement in skin elasticity.

14 Sep 2015

Cynosure obtains European MDD certification for SculpSure

Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received European Medical Device Directive (MDD) certification from its European Notified Body for SculpSure, the world's first hyperthermic aesthetic laser for non-invasive fat reduction. The certification, from Intertek Semko AB, allows Cynosure to place the "CE" Mark on SculpSure for distribution in the European Union and its member states.

10 Sep 2015

Syneron Medical's second quarter 2015 revenue up 14% to $73.5 million

Syneron Medical Ltd., a leading global aesthetic device company, today announced financial results for the three month period ended June 30, 2015.

4 Aug 2015

XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that Asahi Kasei Pharma Corporation has received approval for its regulatory application to the Japanese Pharmaceutical and Medical Device Agency (PMDA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of patients with Dupuytren's contracture in Japan.

20 Jul 2015

Cynosure obtains FDA clearance to market SculpSure for non-invasive reduction of fat from the abdomen

Cynosure, Inc., a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.

7 Jul 2015

Cynosure obtains FDA approval to market SculpSure for non-invasive lipolysis treatment

Cynosure, Inc. a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market SculpSure, the world's first hyperthermic laser treatment for non-invasive lipolysis of the flanks.

19 May 2015

Canfield to become sole supplier of PRIMOS family of 3D optical systems worldwide

Demonstrating its commitment to delivering best-in-class clinical research solutions, Canfield Scientific has been named the exclusive worldwide distributor of the highly respected PRIMOS family of 3D optical systems.

21 Mar 2015

Envy Medical launches world-class patented Advanced Dermalinfusion Technology

Envy Medical, Inc. launches SilkPeel3, the next generation of its world class patented Advanced Dermalinfusion Technology. Unveiled originally in 2005, SilkPeel is celebrating its 10th birthday in style with fresh features, enhanced functionality and a sleek new design.

18 Mar 2015

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.

13 Mar 2015

Chromogenex US, LiLa sign distribution agreement for i-lipo and i-lipo Ultra body sculpting systems

Chromogenex US, Inc., of Howell, Michigan, the sister company of Chromogenex Technologies, Ltd., and LiLa Enterprise, LLC of Suwanee, Georgia, announced today a strategic alliance wherein Chromogenex US appoints LiLa the exclusive distributor for the i- lipo and i-lipo Ultra body sculpting systems that employ low level laser technology for smoothing cellulite, fat reduction and body shaping treatments.

11 Mar 2015

FDA approves Cynosure's new 532 nm Laser Delivery System for PicoSure

Cynosure, Inc. today announced FDA 510(k) clearance of its new 532 nm Laser Delivery System for PicoSure, creating a powerful, dual-wavelength laser system for removing tattoos of all colors in fewer treatments. PicoSure, the world's first picosecond aesthetic laser, is widely recognized for its technology leadership, unmatched clinical versatility and proven performance.

25 Feb 2015

Auxilium Pharmaceuticals presents STENDRA clinical data for ED treatment at SMSNA Scientific Meeting

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that data were presented regarding the use of STENDRA® (avanafil) tablets for the treatment of erectile dysfunction (ED) at the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (SMSNA) held in Miami from November 20-23, 2014.

20 Nov 2014

Auxilium Pharmaceuticals reports total revenues of $109.6 million for Q3 2014

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced financial results for the third quarter ending September 30, 2014.

30 Oct 2014